Brief: Alteogen - Signs Exclusive License Agreement For Alt-B4 Recombinant Human Hyaluronidase
04/08/2026 23:42
BRIEF-Alteogen - Signs Exclusive License Agreement For Alt-B4 Recombinant Human Hyaluronidase Alteogen Inc 196170.KQ:
ALTEOGEN - SIGNS EXCLUSIVE LICENSE AGREEMENT FOR ALT-B4 RECOMBINANT HUMAN HYALURONIDASE
ALTEOGEN - UPFRONT AND MILESTONE PAYMENTS UP TO $365 MILLION
Source text: [ID:]
Further company coverage: 196170.KQ
Recent news on Alteogen
See all newsDeals of the day-Mergers and acquisitions
Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology
Brief: Alteogen To Invest 253 Billion Won In Construction Of New Factory
Brief: Alteogen Q2 Operating. Profit 34.2 Billion Won
Brief: Alteogen - Signs Exclusive License Agreement For Alt-B4 Recombinant Human Hyaluronidase